发明名称 Particulates of the CRTH2 antagonist { 4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)-benzyl)pyrimidin-5-yl} acetic acid
摘要 <p>Disclosed are particulates of { 4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)- benzyl)pyrimidin-5-yl} acetic acid, in crystalline Form I; wherein the crystalline Form I has a differential scanning calorimetric thermogram with an endotherm at a peak temperature of about 224 ºC and an onset temperature of about 220 ºC, wherein the differential scanning calorimetric thermogram is obtained at a heating rate of 10 ºC/min; and the particulates have an average particle size ranging from about 0.1 to about 150 mm; and wherein: the crystalline Form I has an X-ray powder diffraction pattern with one or more peaks expressed in two-theta at approximately 9.8, 13.1, 22.0, and 26.4º. Further disclosed is a process for the preparation of the particulates of { 4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)-benzyl)pyrimidin-5-yl} acetic acid in crystalline Form I, comprising contacting { 4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)- pyrimidin-5-yl} acetic acid with a solvent such as acetonitrile, chloroform, dichloromethane, 1,4-dioxane, 2-methoxyethanol, MIBK, toluene, hexane(s), acetone, 1-butanol, DMSO, ethanol, ethyl acetate, ethyl formate, heptane, isobutyl acetate, 1-propanol, IPA, MEK, THF, water, and mixtures thereof.</p>
申请公布号 NZ581811(A) 申请公布日期 2012.11.30
申请号 NZ20080581811 申请日期 2008.06.18
申请人 ACTIMIS PHARMACEUTICALS, INC. 发明人 LY, TAI, WEI;LI, HUI-YIN
分类号 C07D239/48;A61K31/33;A61P11/06;A61P29/00 主分类号 C07D239/48
代理机构 代理人
主权项
地址